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OBJECTIVES We assessed the impact of serum cholesterol level in early midlife on total mortality during
up to 39 years of follow-up and on the quality of life (QoL) in old age.
BACKGROUND Total effects of low serum cholesterol on health have been in dispute, especially in elderly
persons, and there are few data on the long-term effects of low cholesterol on QoL.
METHODS The cohort consisted of 3,277 healthy businessmen age 30 to 45 years at baseline (1960s). In
addition to baseline, serum cholesterol values were available for part of the cohort in 1974,
1986, and 2000. The QoL was assessed in 80.9% of survivors (n  1,820, mean age 73 years)
with a RAND-36 (SF-36) QoL questionnaire in 2000. Mortality up to 2002 (n 1,173) was
retrieved from national registers.
RESULTS Cholesterol was clearly reduced in survivors during follow-up, except in the lowest baseline
serum cholesterol group. Baseline cholesterol predicted 39-year total mortality in a graded
manner (p  0.0001), and a value 5.0 mmol/l was associated with a 25% reduction in total
mortality. In old age, the physical component summary score of RAND-36 was significantly
(p  0.02) higher (better) in the lowest baseline cholesterol group; no difference was found
in the mental component summary score (p  0.51).
CONCLUSIONS Low serum cholesterol level in midlife predicted not only better survival but also better
physical function and QoL in old age, without adversely affecting mental QoL. (J Am Coll
Cardiol 2004;44:1002–8) © 2004 by the American College of Cardiology Foundationc
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che research behind the current goals of hypolipidemic
herapy is extensive (1,2), and the cardiovascular benefits of
holesterol lowering for five to seven years have been
epeatedly demonstrated (2). Still, there have been contro-
ersies regarding the truly long-term prognostic value of low
holesterol on total mortality, especially in older individuals
See page 1009
3–5). Also the long-term effects of low (or lowered)
holesterol on mental functioning and quality of life (QoL)
ave been in dispute (6,7). Because there are now efficient
rugs to bring cholesterol to low levels, we still need
ong-term data to show that low cholesterol is not harmful.
e present the results on a large group of men who were
nitially healthy, age 30 to 45 years, and whose baseline
holesterol was related not only to total mortality during up
o 39 years of follow-up but also to health-related QoL in
ld age. It should be noted that our study essentially reflects
he association of naturally (or lowered by secular changes)
ow cholesterol levels with mortality because the effects of
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ealth Institute, Helsinki, Finland. The Päivikki and Sakari Sohlberg Foundation,
he Helsinki University Central Hospital, and the Finnish Foundation for Cardio-
ascular Research have provided financial support. Dr. Strandberg is a senior research
ellow of the Academy of Finland (Grant 48613). All authors have cooperated with
ompanies marketing cholesterol-lowering drugs.
Manuscript received December 9, 2003; revised manuscript received April 21,
e004, accepted April 27, 2004.holesterol-lowering drugs are largely restricted to the last
ears of follow-up.
ETHODS
aseline examinations in 1968 to 1973 and follow-up
xaminations in 1974 and 1985. The study population and
xaminations have been described in detail (8–11), and a
ow chart of examinations pertaining to cholesterol is
hown in Figure 1. The follow-up data are comprehensive at
aseline and at the end, whereas the three in-between
valuations include only part of the population.
A total of 3,490 initially healthy men, mostly business
xecutives born in 1919 to 1934, participated in voluntary
ealth check-ups from 1964 to 1973 (median 1968) at the
nstitution of Occupational Health in Helsinki, Finland. At
hat time occupational health care was not customary in
innish companies. The health check-up procedures in-
luded clinical examinations and laboratory tests. Ergometry
as performed, but data were not entered into the database
nd are thus not available for analysis. Only one baseline
easurement of serum cholesterol is available, and between
aseline and the 2000 survey only mortality data were
ollected systematically from all participants. The first
cientific approach (8) was performed in 1974, when the
en consented to an evaluation in which electrocardio-
raphic findings were correlated to risk factors (including
holesterol) and coronary heart disease. The men were also
valuated with mailed questionnaires and laboratory exam-
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September 1, 2004:1002–8 Cholesterol, Mortality, and Quality of Lifenations in order to find healthy participants for a primary
revention study (9). In the questionnaires, 2,696 of the
en (77%) rated their current health and physical fitness on
five-step scale (“very good,” “good,” “fair,” “poor,” or “very
oor”). In 1974, fasting serum cholesterol was measured in
ealthy candidates for the intervention trial (n  2,245),
nd 1,709 of these men were further contacted in 1985 with
uestionnaires and laboratory examinations (cholesterol
easurement in 1,246 men). In contrast to earlier exami-
ations, cholesterol values in 2000 were based on self-report
n questionnaires sent to all survivors of the initial cohort.
The present study on mortality and cholesterol includes
he 3,277 men (94 %) for whom baseline serum cholesterol
easurements were available. Exclusion of the 612 men
ho participated in the 5-year intervention trial during the
970s (9) did not alter the conclusions of the present study,
nd therefore the results of the whole original cohort are
resented.
During the 1960s and 1974, serum cholesterol concen-
ration was determined using the method of Huang et al.
12); since then routine laboratory analyses with enzymatic
ethods have been used. According to our measurements
Abbreviations and Acronyms
MCS  mental component summary
PCS  physical component summary
QoL  quality of life
SF-36  Short Form-36aFigure 1. Flow chart of the study.10), cholesterol levels measured with older methods gave
.3% higher values. Accordingly, 5.0 mmol/l in the 1960s
ould correspond to 4.6 mmol/l measured with an enzy-
atic method. We used the corrected values in the present
nalyses; the conclusions nevertheless remained the same
hen original values were used. In some of the analyses we
ompared the lowest cholesterol group (5.0 mmol/l, n 
24) with other groups combined.
he 2000 survey. In 2000, we sent a mailed questionnaire
re-mailed once for non-respondents) to all survivors of the
riginal cohort, and 1,820 of 2,251 men (80.9%) responded.
he questionnaire included items on demographic variables
nd lifestyle (smoking, alcohol consumption, physical activ-
ty), history of diseases, and the latest serum cholesterol
evel. In addition, the Finnish version of the RAND-36-
tem Health Survey 1.0 (practically identical to the SF-36
ealth survey) (13–15) was embedded in the questionnaire.
he RAND-36 questionnaire has been validated in the
innish population (13).
ortality follow-up. Total mortality of the study popula-
ion was regularly recorded until December 31, 2002. The
ortality data were retrieved (after approval) from Statistics
inland and the Central Population Register, which keeps a
egistry of all Finnish citizens. According to the Register,
ssessment of vital status is very reliable for people having
heir permanent place of residence in Finland (more than
5% of the present cohort in 2000), regardless of whether
hey die in Finland or abroad. Moreover, assessment of the
ital status is also quite reliable for Finnish citizens living
ermanently abroad. Because the study population was
efined as those who were born in 1919 through 1934 and
ttended at least one health check-up between the years
964 and 1973, the total follow-up time of the cohort is up
o 39 years (median 35 years, interquartile range 33 to 37
ears).
tatistical methods. Number Crunching Statistical Sys-
em statistical software (Kaysville, Utah) was used for the
nalyses. In most analyses we compared the lowest baseline
erum cholesterol group (5.0 mmol/l, n 224) with other
roups combined. However, we also present survival anal-
ses according to the baseline cholesterol values divided into
er 1 mmol/l increasing groups (i.e., 5.0 mmol/l [n 
24], 5.1 to 6.0 mmol/l [n  803], 6.1 to 7.0 mmol/l [n 
,170], 7.1 to 8.0 mmol/l [n  720], 8.1 to 9.0 mmol/l [n
255], and 9.0 mmol/l [n  105]). The t tests,
onparametric tests, and analysis of covariance were used
here appropriate to compare continuous variables; chi-
quare tests were used to compare proportions. Differences
n survival curves were analyzed with log-rank tests. Relative
azards with their 95% confidence intervals for mortality
ssociated with baseline serum cholesterol were calculated
sing Cox’s proportional hazards regression. Other risk
actors were adjusted for in respective models. The eight
AND-36 scales (physical function, role physical, bodily
ain, general health, vitality, social function, role emotional,
nd mental health) were calculated from questionnaires
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ary (PCS) and the mental component summary (MCS)
cores were calculated of the RAND-36 scales as instructed
15). In statistical analyses two-tailed tests were used, and P
alues 0.05 were taken as statistically significant.
ESULTS
aseline characteristics and cholesterol tracking. At
aseline, the average age of the cohort (n  3,277) was 37.3
ears, and 44.9% were smokers. All were clinically healthy
nd without cardiovascular diseases or diabetes. Clinical
haracteristics at baseline with comparisons between the
ow-cholesterol group (median serum cholesterol 4.7
mol/l, interquartile range 4.4 to 4.9 mmol/l) and others
re shown in Table 1. In 1974, the distributions of subjec-
ive health and physical fitness did not differ between the
ow-cholesterol group and other groups combined: the p
alues for the overall differences between the groups were
.37 (subjective health) and 0.75 (physical fitness). Only
.3% and 6.6% of the men in the lowest cholesterol group
nd others, respectively, reported their subjective health as
able 1. Risk Factors at Baseline in the Study Population
All
(n  3,277)
Cholestero
(n
ge (in 1964), yrs 38 (4) 3
ody mass index, kg/m2 26 (3) 2
Systolic blood pressure, mm Hg 136 (16) 13
Diastolic blood pressure, mm Hg 86 (11) 8
holesterol, mmol/l 6.6 (1.2) 4
-h glucose, mmol/l 6.3 (1.9) 6
mokers, % 41
ata indicate mean (SD) unless otherwise indicated.
igure 2. Distribution and change of serum cholesterol (mmol/l) according
urvivors who reported their cholesterol value in 2000 (n  1,292). Amon
84), and in 1985 (n  696). At all time points the differences between the bapoor” or “very poor.” The respective proportions were
4.9% and 16.2% for physical fitness. Cholesterol values
racked reasonably well during the long follow-up. Analysis
f the survivors who reported their cholesterol value in 2000
n  1,292) showed that the baseline differences had been
ustained over the years, although the values had decreased
xcept in the lowest baseline cholesterol group (Fig. 2).
ortality during follow-up. During the follow-up there
ere 1,173 deaths (35.8%), and there was a graded associ-
tion between mortality risk and baseline serum cholesterol.
urvival curves of all baseline cholesterol groups and the
owest baseline cholesterol group (5.0 mmol/l) versus
ther groups combined are shown in Figures 3A and 3B,
espectively. Differences were highly statistically significant
ccording to log-rank tests. The curves demonstrate that the
urvival benefit in the lowest cholesterol group was even
ccentuated during the last years of the follow-up. Splitting
he lowest cholesterol group in half (4.7 mmol/l, n 114,
nd 4.7 to 5.0 mmol/l, n  110) did not show further
eduction of mortality risk (mortality 27.2% vs. 24.5%,
espectively; p  0.76 between the lowest groups), but the
umbers were small. In multivariate analyses adjusted for
.0 mmol/l
4)
Cholesterol > 5.0 mmol/l
(n  3,053)
p Value Between
Cholesterol Groups
38 (4) 0.0001
26 (3) 0.19
) 136 (16) 0.003
) 87 (11) 0.02
) 6.8 (1.1) 0.0001
) 6.4 (1.9) 0.05
41 0.45
aseline cholesterol during the follow-up. The analysis was restricted to the
m serum cholesterol was available at baseline (n  1,292), in 1974 (n l < 5
 22
7 (4)
6 (3)
3 (17
5 (12
.6 (0.4
.1 (1.7
38to b
g theseline cholesterol groups were highly significant (p  0.0001).
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September 1, 2004:1002–8 Cholesterol, Mortality, and Quality of Lifege only or for age and cardiovascular risk factors, every
-mmol/l increase of baseline cholesterol increased mortal-
ty risk by 11% (Table 2). The comparison between the
owest cholesterol groups and other groups combined was
ssociated with 25% lower mortality, and the relative hazard
as quite insensitive to the inclusion of a number of
ovariates (Table 2).
000 survey of risk factors, morbidity, and QoL. Am-
ng survivors (average age 73 years, standard deviation 4),
he response rate in 2000 was 80.9% (n  1,820). Age
igure 3. Survival curves of all baseline cholesterol groups (A, n  3,277)
nd the lowest cholesterol group (5.0 mmol/l, n  224) versus other
roups combined (B). p value in both panels denote the significance of the
urvival differences between the cholesterol groups (log-rank test). I: 5.0
mol/l (n  224), II: 5.1 to 6.0 mmol/l (n  803), III: 6.1 to 7.0 mmol/l
n  1,170), IV: 7.1 to 8.0 mmol/l (n  720), V: 8.1 to 9.0 mmol/l (n 
55), VI: 9.0 mmol/l (n  105).
Table 2. Multivariate Relative Hazard of 39-Y
in the Total Cohort (n  3,277)
Baseline Cholesterol Mode
Continuous variable, per 1 mmol/l 1.11 (1.05
p Value  0.0
5.0 mmol/l (n  224) 0.76 (0.59
p Value 0.0
*Relative hazard calculated using the Cox proportional hazard
Model B: adjusted for age, body mass index, and the year of fi
index, smoking, systolic blood pressure, 1-h glucose (log transformnd baseline cholesterol concentrations were identical in
espondents and non-respondents. Men of the lowest
aseline cholesterol group (5.0 mmol/l, n  144)
eported less coronary heart disease (p  0.002) and
erebrovascular disease (p  0.04) than men of the other
roups combined, whereas self-reported prevalences of
iabetes, cancer, and mental diseases were not statistically
ifferent (Table 3). Altogether, 84% of the men had some
egular medication, and 16% used cholesterol-lowering
rugs (statins).
Summary scores of the health-related QoL instrument
RAND-36) in the lowest versus combined other choles-
erol groups are shown in Figure 4. All the differences
revailed after the effect of multiple comparisons was
aken into account. Physical component score (PCS,
djusted for age, baseline smoking, BMI, and blood
ressure) was significantly better in the lowest cholesterol
roup (47.6 vs. 45.4 in other groups combined, p  0.02),
hereas the MCS was similar between the cholesterol
roups (52.3 vs. 52.9 in other groups combined, p 
.51). If the lowest cholesterol group was split in half,
CS was even better in the 4.7 mmol/l group (average
CS 48.9), but the difference with the 4.7 to 5.0 mmol/l
roup (average PCS 47.1) was not statistically significant
p  0.2).
ISCUSSION
he results in this homogenous, and now elderly, male
opulation show that during almost 40 years of follow-up,
erum cholesterol significantly and in a graded fashion
redicted total mortality. Although original cholesterol
ifferences had largely leveled off in the old survivors, the
en with cholesterol level 5.0 mmol/l at baseline had the
est prognosis. Besides better survival, low cholesterol was
lso associated with better health-related QoL in old age.
This is one of the longest follow-up studies of serum
holesterol, and the results are based on a relatively large
ohort of men. They were healthy (no cardiovascular dis-
ases or diabetes) and without hypolipidemic medications at
aseline, and in midlife cholesterol level was not yet asso-
iated with subjective health or physical fitness. Mortality
ollow-up with national registers was reliable and during the
9-year follow-up there were a substantial number of
ortality According to Baseline Cholesterol
Relative Hazard*
Model B Model C
) 1.11 (1.06–1.17) 1.09 (1.04–1.15)
 0.0001 0.001
) 0.75 (0.57–0.98) 0.72 (0.53–0.97)
0.04 0.04
el (with 95% confidence interval). Model A: adjusted for age.
lesterol measurement. Model C: adjusted for age, body massear M
l A
–1.16
001
–1.00
5
s mod
rst choed), and the year of first cholesterol measurement.
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Cholesterol, Mortality, and Quality of Life September 1, 2004:1002–8eaths. Health-related QoL was measured with an interna-
ional instrument, validated also for the Finnish population.
he cohort was homogenous, with all men from the highest
ocial class, eliminating the possibly important confounding
ffect of socioeconomic status.
Our results both support and extend earlier studies. In
ddition to shorter but very large follow-up studies, such as
he Multiple Risk Factor Intervention Trial population (16),
ther truly long-term studies (over 20 years) have demon-
trated that cholesterol predicts not only cardiovascular
ortality but also total mortality (17–19). More dispute has
risen regarding the association of low cholesterol and
Table 3. Self-Reported Risk Factors and Disea
Cholesterol Level
Cholesterol <
(n 
Body mass index, kg/m2 26 (4
Systolic blood pressure, mm Hg 144 (1
Diastolic blood pressure, mm Hg 82 (1
Cholesterol, mmol/l* 4.7 (0
Glucose, mmol/l 5.5 (0
Smokers, % 9
Alcohol consumption, gs/week 101 (1
No regular exercise, % 15
Diabetes, % 8
Coronary heart disease, % 11
Congestive heart failure, % 14
Cerebrovascular disease, % 7
Peripheral artery disease, % 13
Cancer, % 16
Pulmonary disease, % 5
Musculoskeletal disease, % 20
Mental disease, % 2
Any chronic disease, % 64
Data for continuous variables are mean (SD). *Reported
respectively.
igure 4. Baseline cholesterol and health-related quality of life (RAND-
6, adjusted for age and baseline body mass index, systolic blood pressure,
nd smoking) in old age in 2000. The original physical component
ummary and the mental component summary scores were calculated
ccording to the RAND-36 scales as described in Methods. Solid bars nholesterol 5.0 mmol/l; open bars  5.0 mmol/l.ortality in elderly persons. For example, in the Honolulu
eart Program (5) low cholesterol was associated with
reater mortality risk. Obvious explanations for the associ-
tion are intervening factors that both increase mortality risk
nd decrease the cholesterol level. In the nine-year
ollow-up of the Helsinki Aging Study, mortality risk was
ssociated with both lowered cholesterol synthesis and
owered cholesterol absorption (20), which reflect terminal
ecline and lead to lower serum cholesterol levels. These
ssociations are not identified, and the relationship between
holesterol and mortality becomes distorted unless the
ollow-up is long enough. Figure 2 demonstrates that quite
ormal cholesterol levels in old age may have been substan-
ially higher in the same individuals earlier in life. This
evelopment of decreasing levels may have a variety of
nderlying explanations. Besides intervening conditions,
uch as chronic diseases, which lower serum cholesterol, the
rend between 1968 and 1974 is mostly due to regression to
he mean. From 1974 onward a contributing factor is the
ecular lowering trend of cholesterol levels observed in the
innish population in recent decades (21). In the whole
ohort, the use of cholesterol-lowering drugs was negligible
uring the major part of the follow-up; in the 1985 survey
nly 3% used these medications. However, their use has
bviously contributed to the latest cholesterol values, as 16%
f men reported use of cholesterol-lowering drugs (statins)
n the 2000 survey.
Much debate has arisen as to whether and to what extent
ow cholesterol is associated with unwanted side effects; for
xample, adverse effects on mental functioning have been
uspected (8,9). Our results on the health-related QoL do
n Study Groups in 2000 by the Baseline
mol/l Cholesterol > 5.0 mmol/l
(n  1,667) p Value
26 (4) 0.67
143 (16) 0.53
82 (17) 0.57
5.3 (1.0) 0.0001
5.6 (1.3) 0.88
7 0.35
125 (142) 0.22
21 0.08
12 0.19
24 0.002
15 0.68
14 0.04
17 0.29
15 0.73
10 0.07
27 0.05
4 0.22
70 0.13
and 1,203 men in the low and high cholesterol groups,ses i
5.0 m
144)
)
6)
1)
.7)
.9)
11)
by 89ot corroborate these fears. Instead, there are significantly
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September 1, 2004:1002–8 Cholesterol, Mortality, and Quality of Lifeetter scores reflecting physical functioning in old age in
en with lowest cholesterol values at baseline. In all, the
CS was significantly better in men with low cholesterol.
ccording to the calculated norms (15), the 2-point differ-
nce in PCS between the groups in 2000 would mean a
ostponement of disability by 2 years in the low-cholesterol
roup compared with men with higher cholesterol levels. A
elay of even this magnitude may have substantial impact in
he expanding geriatric population. The obvious explanation
or less disability is that there is less cardiovascular disease,
specially coronary heart disease, among men with low
holesterol. However, it is equally important that low
holesterol is not associated with adverse effects on mental
unctioning over the long term. Again we remind that the
resent results apply to naturally low cholesterol levels.
trictly, these long-term results cannot be extrapolated to
rug-induced cholesterol lowering, although it is now
nown that statins can reduce mortality at least up to eight
ears (22).
Some limitations of the study should be mentioned.
he study population is selective, with all participants
eing men from the highest social class. Thus, extrapo-
ation of the results to the general population (and
specially to women) should be done cautiously. How-
ver, in the present study we examined within-group
ifferences, which are probably less sensitive to the
elective nature of the cohort. Another possible limitation
f the study is that only one baseline serum cholesterol
easurement was available, and the last cholesterol value
in 2000) was based on self-report of the participants.
owever, the tracking of serum cholesterol in survivors
as good and consistent over the years. Furthermore, we
easured serum cholesterol in 131 of the men in 2003,
nd the agreement was satisfactory between this mea-
ured value and the reported value in 2000. The propor-
ion of men with low cholesterol (5.0 mmol/l) at
aseline was relatively small, but this was a reality in
inland (and many other western countries) 40 years ago.
uality-of-life measurements tended to be even better in
en with cholesterol 4.7 mmol/l. Finally, the presence
f various diseases in 2000 was also based on self-report.
owever, we validated coronary disease and stroke mor-
idity in this cohort up to 1990 from national registers
23), and even these older vascular events were reported
o a high degree by the men in 2000 (85% of coronary
vents, 80% of stroke events). Overall, we think that
elf-report in this cohort of high social status is reliable.
In conclusion, our study shows that men with the lowest
erum cholesterol levels in early midlife have the lowest total
ortality during almost 40 years of follow-up. Among
urvivors in old age, low baseline cholesterol was associated
ith better physical health. Importantly, these long-term
esults show no adverse association between low baseline
holesterol and mental health.eprint requests and correspondence: Dr. Timo E. Strandberg,
epartment of Medicine, University of Helsinki, P.O. Box 340,
IN-00029 HUS, Helinski, Finland. E-mail: timo.strandberg@
us.fi.
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